NRX Pharmaceuticals (NRXP) EPS (Diluted) (2020 - 2026)
Powered by 
Analysis
NRX Pharmaceuticals (NRXP) EPS (Diluted) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.69 Bn | 192.70 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 179.87 Bn | 176.70 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 81.70 Bn | 73.71 Bn | 3.93 Bn | 12.23 |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | 7.15 |
| 6 | Moderna | 54.28 Bn | 49.14 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.02 Bn | 29.71 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 31.93 Bn | 30.64 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.27 Bn | 29.27 Bn | 1.16 Mn | -0.40 |
| 10 | NRX Pharmaceuticals | 128.38 Mn | 101.68 Mn | 426,000.00 | -0.76 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.76 |
| Mar 31, 2026 | -0.56 |
| Dec 31, 2025 | -0.60 |
| Sep 30, 2025 | -0.45 |
| Jun 30, 2025 | -0.42 |
| Mar 31, 2025 | -0.43 |
| Dec 31, 2024 | -0.27 |
| Sep 30, 2024 | -0.34 |
| Jun 30, 2024 | -0.80 |
| Mar 31, 2024 | -0.70 |
| Dec 31, 2023 | -0.54 |
| Sep 30, 2023 | -0.70 |
| Jun 30, 2023 | -1.10 |
| Mar 31, 2023 | -0.57 |
| Dec 31, 2022 | -1.56 |
| Sep 30, 2022 | -1.37 |
| Jun 30, 2022 | -1.06 |
| Mar 31, 2022 | -2.47 |
| Dec 31, 2021 | -6.48 |
| Sep 30, 2021 | -7.26 |